Literature DB >> 3655119

Speaking rate of adventitiously deaf male cochlear implant candidates.

S B Leder1, J B Spitzer, J C Kirchner, C Flevaris-Phillips, P Milner, F Richardson.   

Abstract

No objective group data on speaking rate or speaking duration have been reported on the speech of adventitiously profoundly hearing-impaired adults. Results of the present study showed that speaking rate, i.e., number of syllables per second, was significantly slower and speaking duration was significantly longer for 25 adventitiously profoundly hearing-impaired adult male cochlear implant candidates than for 10 normal-hearing control subjects. The factors of length of time since onset of profound hearing loss and hearing aid use did not significantly affect speaking rate. Based on these objective data, a rationale and method are presented for aural rehabilitation of the profoundly hearing-impaired who exhibit speaking rate abnormalities.

Entities:  

Mesh:

Year:  1987        PMID: 3655119     DOI: 10.1121/1.395283

Source DB:  PubMed          Journal:  J Acoust Soc Am        ISSN: 0001-4966            Impact factor:   1.840


  4 in total

1.  Postlearning consolidation of birdsong: stabilizing effects of age and anterior forebrain lesions.

Authors:  M S Brainard; A J Doupe
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

2.  Speech timing and working memory in profoundly deaf children after cochlear implantation.

Authors:  Rose A Burkholder; David B Pisoni
Journal:  J Exp Child Psychol       Date:  2003-05

3.  Immediate effects of cochlear implantation on voice quality.

Authors:  S B Leder; J B Spitzer; J C Kirchner
Journal:  Arch Otorhinolaryngol       Date:  1987

4.  The effect of cochlear implantation and post-operative rehabilitation on acoustic voice analysis in post-lingual hearing impaired adults.

Authors:  Sabah M Hassan; Khalid H Malki; Tamer A Mesallam; Mohamad Farahat; Manal Bukhari; Thomas Murry
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-02-18       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.